my.chemeurope.com
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
European travelling exhibition and seminar tour designed to provide customers with answers to their unmet biosafety challenges, directly at their facilities. Unique opportunity to find biosafety solutions that improve significantly their process efficiency and ensure an appropriate risk management.
Topics:
-sterile filtration
-virus safety
-sterile connections
-sterile sampling
-cell culture
-bioburden monitoring
-rapid microbiology
-sterility testing.
Target: decision-makers, managers, supervisors and scientists working in the biotech, vaccine and plasma industry from process development to production including QA/QC.
Program:
-Hands-on, discussions, scientific posters and micro-conferences will be animated by Millipore application and technology
-Millipore’s innovative products and services, as well as integrated solutions for biosafety insurance in bioprocessing
-market trends and Regulatory updates.
Gratis
| Event Date: | 10-06-2010 | |
| Event Location: |
Biotechnica, Hannover
Germany |
|
| Event Organiser: |
Millipore SAS
Virginie Isner Laemmel 39 route industrielle de la Hardt – Bât E 67120 Molsheim France |
Contact / Request information
Contact the event organiser and request further information free of charge:
Watchlist
This is where you can add this event to your personal favourites
Additional Information
Merck KGaA Completes Millipore Acquisition and Launches New Merck Millipore Division
Merck KGaA announced the successful completion of its acquisition of Millipore Corporation, a leading Life Science company based in Billerica, Massachusetts, USA, for an aggregate purchase price including debt and cash of approximately EUR 5.2 billion (US$ 7.0 billion). Merck agreed to acqu ... more
Merck KGaA to acquire all outstanding Millipore shares for US$ 107 per share in cash
Merck KGaA and Millipore Corporation announced that they have entered into a definitive agreement under which Merck KGaA will acquire all outstanding shares of common stock of Millipore, for US$ 107 per share in cash, or a total transaction value, including net debt, of approximately € 5.3 ... more
Millipore Names New VP of Life Science Business Unit
Millipore Corporation announced the appointment of John Sweeney as Vice President of Millipore’s Life Science SBU. Most recently, Sweeney served as Vice President of Strategy and Marketing services for Millipore’s Bioscience Division. Sweeney joined Millipore in 2003 as Director of Strateg ... more
Millipore is a life science leader providing cutting edge technologies, tools, and services for bioscience research and biopharmaceutical manufacturing. As a strategic partner, we collaborate with customers to confront the worlds challenging human health issues. From research to development ... more
Millipore is a multinational company with offices and subsidiaries in 47 countries and distributors and dealers in other countries. There are manufacturing sites and R&D sites around the world. With its global infrastructure, Millipore services multinational pharmaceutical and biotechnology ... more
About CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2012 CHEMIE.DE Information Service GmbH, All rights reserved
